Diagnosis and Management of Hypertension Davin Haraway DO,FACOI,CWS Associate Professor of Medicine – OSU Center for Health Sciences.

Slides:



Advertisements
Similar presentations
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
Advertisements

Measuring Blood Pressure
Treatment-Resistant Hypertension: Diagnosis and Management Power Over Pressure
SUPERVISED BY Dr. Essmat Gemeay Outline: Interdiction Definition Causes Complication Risk facture Sings and symptoms Diagnostic study management Nursing.
Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension –
 Cure Pathologic Fear of Hypertension  Create Rational Approach to Drug Choice  Complement Rational Choice with Pearls  Consolidate new information.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
High Blood Pressure (Hypertension) Prevention and Control SASH – September 25, 2012 Suzanne Lapointe, RN, BA, CNN Fletcher Allen Health Care, Nephrology.
Hypertension Dr. Meg-angela Christi Amores. Hypertension doubles the risk of cardiovascular diseases present in all populations except for a small number.
Epidemiology Prevalence Increase with age 25% of the white males vs. 17% in white females 44% of black males vs. 37% in black femals Indifference between.
In the Name of God In the Name of God Overview of Hypertension Mahboob Lessan Pezeshki MD Tehran University of Medical Sciences Aban 1392.
©2007 RUSH University Medical Center Hyperuricemia in adolescents with primary hypertension: how and when to intervene? Farahnak Assadi, M.D. Professor.
Hypertension: JNC 7 Guidelines Steven W Harris MHS PA-C.
Pharmacological Treatment of Hypertension Update 2012.
Hypertensive Management in the Asymptomatic Patient: First do no harm Steven A Godwin MD, FACEP University of Florida, COM-Jacksonville Ponte Vedra 2007.
Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.
Drugs for Hypertension
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
Hypertension in Childhood: Diagnosis & Management.
DR. IDOWU AKOLADE EDM DIVISION LUTH
Dr. Atapour Nephrologist. Hypertension Blood pressure levels are a function of cardiac output multiplied by peripheral resistance (the resistance in.
Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.
CARDIOVASCULAR MODULE: HYPERTENSION Adult Medical-Surgical Nursing.
1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
 Update on Hypertension Troy L. Randle, DO, FACC, FACOI.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Investigations: Urine examination. Urine examination. Serum K. Serum K. Serum creatinine. Serum creatinine. Blood Sugar. Blood Sugar. Hb. Hb.
Hypertension (High Blood Pressure)
HYPERTENSIVE CRISIS MOHAMMED R ARAFAH MBBS FACP FRCPC FACC PROFESSOR OF CARDIOLOGY.
Racial, genetic, life style influence: Type extent of complications (renal failure and stroke are more common in blacks). Response to dietary therapy (low.
بیماریهای ادرنال. Endocrine Hypertension Hypertension (HT) is the most prevalent cardiovascular disorder and a major public health problem in the United.
RESISTANT HYPERTENSION
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Clinical Aspects of Hypertension Anna Maio, M.D..
Hypertension Dr Nidhi Bhargava 8/10/13. Why Treat Increased risk of cardiovascular death and mortality Increased systolic, diastolic and pulse pressures.
Radka Adlová Arterial hypertension and preventive cardiology.
Hypertension Dr. Gerrard Uy. Hypertension doubles the risk of cardiovascular diseases present in all populations except for a small number of individuals.
Primary Aldosteronism Paul S. Kellerman, M.D., FACP Associate Professor Division of Nephrology.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Antihypertensive Drugs
Baseline Prevalence of Metabolic Syndrome and Individual Components Among 4258 Older Adults Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:
HYPERTENSION Pathophysiology Dr. Zahoor Ali Shaikh 1.
Blood Pressure Anatomy & Physiology.  Measurement of the pressure of the blood exerted against the walls of the arteries.
Therapeutics Conference. Fluid Resuscitation Early correction of fluid deficit is essential in hypovolemic shock to prevent decline in tissue perfusion.
Hypertension Catherine Florio Pipas, MD Community & Family Medicine 2007.
HTN & CKD 1. HTN has been reported to occur in 85-95% of patients with CKD (stages 3–5). The relationship between HTN & CKD is cyclic in nature. Uncontrolled.
Measuring Blood Pressure. Diagnostic Criteria for HTN Two or more separate occasions – BP > 140/90 –Average of Seated Standing for > 2 min Seated with.
Monday, July 25 th,  Diagnostic Evaluation  COST  Confirm the diagnosis  Organize a diagnostic approach  Determine the Severity of the HTN.
Resistant Hypertension - Primary Aldosteronism - 내분비 대사 내과 R3 송 란.
Resistant Hypertension Topic Discussion Brian Skinner, PharmD PGY-1 Pharmacy Resident St. Vincent Indianapolis Hospital.
Hypertension in primary care
Clinical Management of primary hypertension
HTN management in clinic and evaluation of secondary causes
Hypertension In The Stroke Patient
Hypertension guidelines What’s all the controversy about 2015
JNC VIII Hypertension.
Judith H. Veis, MD, FACP Associate Director, Nephrology
Drugs for Hypertension
Hypertension.
What’s New in the 2013 ESC/ESH Hypertension Guideline
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Hypertension Management for Primary Care: Current Recommendations
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Primary Hypertension Max C. Reif, M.D.
Pharmacological Treatment of Hypertension Update 2012
Measuring Blood Pressure
JNC Evidence-Based Guideline for the Management of
Presentation transcript:

Diagnosis and Management of Hypertension Davin Haraway DO,FACOI,CWS Associate Professor of Medicine – OSU Center for Health Sciences

Why talk about the Same Old Thing? ● Those age 55 with normal blood pressure will have a 90 percent lifetime risk of developing hypertension ● Hypertension control reduces excess morbidity and mortality. ● Beginning with 115/75 – CVD risk doubles for each increment of 20/10mmHg ● >50million americans have High Blood Pressure warranting some form of treatment ● 30% adults are still unaware of their hypertension ● >40% of individuals with hypertension are not on treatment ● 2/3 of patients on treatment are not controlled to BP levels of less than 140/90 ● Hypertensive patients are 2.5 times more likely to develop diabetes within 5 years

Risk of hypertension (%) Residual lifetime risk of developing hypertension among people with blood pressure <140/90 mmHg Years Lifetime Risk of Developing Hypertension Beginning at Age 65 MenWomen Vasan RS, et al. JAMA. 2002; 287: Copyright 2002, American Medical Association. g

Table 1. Classification and Management of Blood Pressure for Adults Aged 18 Years or Older HTN Classification

?Prehypertension ● NOT a DISEASE category – Should encourage Lifestyle modification as this group has an increased risk of becoming hypertensive ● NOT candidates for drug therapy (unless compelling indications ie DM etc goal <130/80)

Table 3. Lifestyle Modifications to Manage Hypertension*

Physician Practices in Treating HTN With and Without Diabetes Hyman DJ, Pavlik VN. Arch Intern Med. 2000;160(15): Reprinted by permission, American Medical Association. DBP (mmHg) to Start Treatment % of respondents

Accurate BP measurement ● Who checks your patients BP? – You or Staff ● IF Staff – Do they know what to listen for or do they use automated equipment – Seated quietly for 5 minutes – Appropriate size cuff – Inflate mmHg above loss of radial pulse – Deflate at 2mmHg per second – 1 st sound SBP ; Disappearance of Korotkoff sound (phase 5) is DBP – Confirm Elevated blood pressure within 2months(stage 1) – shorter for stage 2 if new onset

If HTN diagnosed Evaluate for Cardiovascular Risk Factors Age,Fm Hx, Lipids, Obesity, microalbuminuria, Inactivity,Smoking Evaluate for Target Organ Damage LVH or reduced EF, Angina,stroke,dementia,Kidney disease, PAD,retinopathy Think about Secondary Hypertension with any new onset Hypertension or uncontrolled hypertension

Identifiable causes of hypertension ● Chronic kidney disease\ ● Coarctation of the Aorta ● Cushing’s Syndrome ● Drug induced ● Obstructive uropathy ● Pheochromocytoma ● Primary aldosteronism and other mineralocorticoid excess states ● Renovascular HTN – stenosis and fibromuscular dysplasia ● Sleep Apnea ● Thyroid (either HYPER or HYPO) or parathyroid disease

Box 3. Causes of Resistant Hypertension Improper blood pressure measurement Volume overload and pseudotolerance Excess sodium intake Volume retention from kidney disease Inadequate diuretic therapy) Drug-induced or other causes Nonadherence Inadequate doses Inappropriate combinations Nonsteroidal anti-inflammatory drugs; cyclooxygenase 2 inhibitors Cocaine, amphetamines, other illicit drugs Sympathomimetics (decongestants, anorectics) Oral contraceptives Adrenal steroids Cyclosporine and tacrolimus Erythropoietin Licorice (including some chewing tobacco) Selected over-the-counter dietary supplements and medicines (eg, ephedra, ma haung, bitter orange) Associated conditions Obesity Excess alcohol intake Identifiable causes of hypertension (see Box 2)Box 2

Which Drugs do you use? ● Stage 1 – Thiazide 1 st unless compelling indication ● Stage 2 – Two drugs (one of the two should be a diuretic or ACE/ARB) ● Compelling Indications for certain disease modifying meds should be considered

Table 6. Clinical Trial and Guideline Basis for Compelling Indications for Individual Drug Classes

Table 4. Oral Antihypertensive Drugs*

Table 5. Combination Drugs for Hypertension

OK Now what? ● 2/3 of patients with hypertension will need at least two medicines for BP control

Pearls ● For resistant HTN – sit down and take a good history – How much water,pop, coffee,milk,juice,tea,ice – anything liquid do you drink daily. – Food preferences and salt intake – Drugs/Alcohol – Compliance

Pearls cont. ● The only thiazide that will work with an elevated creat. Is metolazone(zaroxolyn) ● If elevated creat. Than will need to use a loop diuretic ● If potassium is elevated – evaluate current meds and use a diuretic ● If potassium is low – ask why ● Check for edema – and ask why ● Elderly patients benefit from blood pressure management ● Black patients benefit from ACE/ARB – may need to use larger doses to obtain BP lowering effect

Pearls Cont. ● Metabolic acidosis and hyperkalemai? – use diuretic – loop if creat. Elevated ● Take blood pressure periodically lying and standing so as not to miss supine hypertension associated with autonomic insufficiency – this is treated differently

Escape of Angiotensin II Despite ACE Inhibition Biollaz J, et al. J Cardiovasc Pharmacol. 1982;4(6): Plasma Ang II (pg/mL) Plasma ACE (nmoL/mL/min) * * * * * * * * * Placebo4 h24 h HospitalMonths *P <.001 vs placebo

Osterberg, L. et al. N Engl J Med 2005;353: Adherence to Medication According to Frequency of Doses

Osterberg, L. et al. N Engl J Med 2005;353: Barriers to Adherence

Figure. Algorithm for Treatment of Hypertension